These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33673803)

  • 1. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
    Nishina S; Tomiyama Y; Ikuta K; Tatsumi Y; Toki Y; Kato A; Kato K; Yoshioka N; Sasaki K; Hara Y; Hino K
    BMC Gastroenterol; 2021 Mar; 21(1):111. PubMed ID: 33673803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
    Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
    Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 4B hereditary hemochromatosis due to heterozygous p.D157A mutation in SLC40A1 complicated with hypopituitarism.
    Honma Y; Karasuyama T; Kumamoto K; Shimajiri S; Toki Y; Tatsumi Y; Sumida K; Koikawa K; Morino K; Oe S; Miyagawa K; Yamasaki M; Shibata M; Abe S; Ikuta K; Hayashi H; Harada M
    Med Mol Morphol; 2021 Mar; 54(1):60-67. PubMed ID: 32607777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC40A1-related hemochromatosis associated with a p.Y333H mutation in mainland China: a pedigree report and literature review.
    Li Y; Duan F; Yang S
    BMC Med Genomics; 2024 Jun; 17(1):161. PubMed ID: 38886778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroportin Disease Caused by a Heterozygous Variant p.Cys326Phe in the SLC40A1 Gene and the Efficacy of Therapeutic Phlebotomy in Children.
    Shimura M; Nishimata S; Saito N; Tsutsumi N; Suzuki S; Morishima Y; Kashiwagi Y; Numabe H; Kawashima H
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):e325-e328. PubMed ID: 30130274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
    Mayr R; Janecke AR; Schranz M; Griffiths WJ; Vogel W; Pietrangelo A; Zoller H
    J Hepatol; 2010 Nov; 53(5):941-9. PubMed ID: 20691492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.
    Kawabata H
    Int J Hematol; 2018 Jan; 107(1):31-43. PubMed ID: 29134618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of iron overload during pregnancy and childbirth in a patient with ferroportin disease].
    Ohara K; Tsuge N; Watanabe S; Eda H; Ogasawara F; Kondo T; Yoshida S; Kojima K
    Rinsho Ketsueki; 2023; 64(11):1410-1414. PubMed ID: 38072426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A farewell to phlebotomy-use of placenta-derived drugs Laennec and Porcine for improving hereditary hemochromatosis without phlebotomy: a case report.
    Hamada Y; Hirano E; Sugimoto K; Hanada K; Kaku T; Manda N; Tsuchida K
    J Med Case Rep; 2022 Jan; 16(1):26. PubMed ID: 35065677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dual loss and gain of function of the FPN1 iron exporter results in the ferroportin disease phenotype.
    Uguen K; Le Tertre M; Tchernitchko D; Elbahnsi A; Maestri S; Gourlaouen I; Férec C; Ka C; Callebaut I; Le Gac G
    HGG Adv; 2024 Oct; 5(4):100335. PubMed ID: 39039793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
    Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
    Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload.
    Bondi A; Valentino P; Daraio F; Porporato P; Gramaglia E; Carturan S; Gottardi E; Camaschella C; Roetto A
    Haematologica; 2005 Sep; 90(9):1161-7. PubMed ID: 16154838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease.
    Viveiros A; Panzer M; Baumgartner N; Schaefer B; Finkenstedt A; Henninger B; Theurl I; Nachbaur K; Weiss G; Haubner R; Decristoforo C; Tilg H; Zoller H
    Liver Int; 2020 Aug; 40(8):1941-1951. PubMed ID: 32450003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Theurl M; Lederer D; Haufe H; Dietze O; Strasser M; Datz C; Weiss G
    Am J Clin Nutr; 2008 May; 87(5):1374-83. PubMed ID: 18469261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron chelators reverse organ damage in type 4B hereditary hemochromatosis: Case reports.
    Wu LY; Song ZY; Li QH; Mou LJ; Yu YY; Shen SS; Song XX
    Medicine (Baltimore); 2021 Apr; 100(13):e25258. PubMed ID: 33787609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemochromatosis.
    Brissot P; Pietrangelo A; Adams PC; de Graaff B; McLaren CE; Loréal O
    Nat Rev Dis Primers; 2018 Apr; 4():18016. PubMed ID: 29620054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare types of genetic hemochromatosis.
    Camaschella C; Poggiali E
    Acta Haematol; 2009; 122(2-3):140-5. PubMed ID: 19907151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ferroportin disease.
    Pietrangelo A
    Blood Cells Mol Dis; 2004; 32(1):131-8. PubMed ID: 14757427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.